Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berodual Respimat vs MDI in pediatric asthma
NCT02182505Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 1998
- Primary completion
- Jul 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fenoterol + ipratropium in asthma, sponsored by Boehringer Ingelheim. Started Sep 1998; status: completed.
02
Drugs
fenoterol + ipratropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02182505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182505.